Page last updated: 2024-10-21

n-methyl-3,4-methylenedioxyamphetamine and Budd-Chiari Syndrome

n-methyl-3,4-methylenedioxyamphetamine has been researched along with Budd-Chiari Syndrome in 1 studies

N-Methyl-3,4-methylenedioxyamphetamine: An N-substituted amphetamine analog. It is a widely abused drug classified as a hallucinogen and causes marked, long-lasting changes in brain serotonergic systems. It is commonly referred to as MDMA or ecstasy.
3,4-methylenedioxymethamphetamine : A member of the class of benzodioxoles that is 1,3-benzodioxole substituted by a 2-(methylamino)propyl group at position 5.

Budd-Chiari Syndrome: A condition in which the hepatic venous outflow is obstructed anywhere from the small HEPATIC VEINS to the junction of the INFERIOR VENA CAVA and the RIGHT ATRIUM. Usually the blockage is extrahepatic and caused by blood clots (THROMBUS) or fibrous webs. Parenchymal FIBROSIS is uncommon.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Taş, A1
Kara, B1
Yılmaz, C1
Suat Yalçın, M1
Dilek, O1
Olmez, S1
Saritas, B1

Other Studies

1 other study available for n-methyl-3,4-methylenedioxyamphetamine and Budd-Chiari Syndrome

ArticleYear
Fulminant Budd-Chiari syndrome due to ecstasy.
    Clinics and research in hepatology and gastroenterology, 2017, Volume: 41, Issue:1

    Topics: Adult; Ascites; Budd-Chiari Syndrome; Diagnosis, Differential; Hallucinogens; Hepatomegaly; Humans;

2017